Celon Pharma Stock

Celon Pharma EBITDA per Employee

The EBITDA per Employee of Celon Pharma (CLN.WA) as of Aug 17, 2026 is 31,035.09 PLN. In the previous year, EBITDA per Employee was 42,226.12 PLN — a change of -26.50% (lower).

EBITDA per Employee

31,035.09PLN

YoY

-26.50%

Last updated:

EBITDA per Employee of Celon Pharma is 2026 31,035.09 PLN. EBITDA per Employee of Celon Pharma was 2025 42,226.12 PLN. It decreases by -26.50% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Celon Pharma Stock analysis

What does Celon Pharma do? Celon Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Celon Pharma stock

EBITDA per Employee of Celon Pharma is 31,035.09 PLN in 2026.

EBITDA per Employee of Celon Pharma changed from 42,226.12 PLN to 31,035.09 PLN, representing a -26.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Celon Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Celon Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Celon Pharma

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Celon Pharma